These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12176112

  • 21. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 22. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.
    Abalo R, Cabezos PA, López-Miranda V, Vera G, González C, Castillo M, Fernández-Pujol R, Martín MI.
    Neurogastroenterol Motil; 2009 Sep 01; 21(9):1002-e80. PubMed ID: 19413685
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat.
    Szabo B, Than M, Thorn D, Wallmichrath I.
    J Pharmacol Exp Ther; 2004 Sep 01; 310(3):915-25. PubMed ID: 15123767
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov 01; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 25. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR, Koek W.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):70-6. PubMed ID: 17553486
    [Abstract] [Full Text] [Related]

  • 26. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
    Malinowska B, Godlewski G, Bucher B, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug 13; 356(2):197-202. PubMed ID: 9272725
    [Abstract] [Full Text] [Related]

  • 27. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.
    Casu MA, Porcella A, Ruiu S, Saba P, Marchese G, Carai MA, Reali R, Gessa GL, Pani L.
    Eur J Pharmacol; 2003 Jan 10; 459(1):97-105. PubMed ID: 12505538
    [Abstract] [Full Text] [Related]

  • 28. Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia.
    Richter A, Löscher W.
    Eur J Pharmacol; 2002 Nov 15; 454(2-3):145-51. PubMed ID: 12421641
    [Abstract] [Full Text] [Related]

  • 29. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P, Calandra B, Legoux P, Kernéis A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Jul 28; 401(1):17-25. PubMed ID: 10915832
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
    Tyler K, Hillard CJ, Greenwood-Van Meerveld B.
    Eur J Pharmacol; 2000 Dec 08; 409(2):207-11. PubMed ID: 11104836
    [Abstract] [Full Text] [Related]

  • 31. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR, Terminelli C, Denhardt G.
    J Pharmacol Exp Ther; 2000 Apr 08; 293(1):136-50. PubMed ID: 10734163
    [Abstract] [Full Text] [Related]

  • 32. Cannabinoid penetration into mouse brain as determined by ex vivo binding.
    Petitet F, Jeantaud B, Bertrand P, Imperato A.
    Eur J Pharmacol; 1999 Jun 25; 374(3):417-21. PubMed ID: 10422786
    [Abstract] [Full Text] [Related]

  • 33. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain.
    Mato S, Pazos A, Valdizán EM.
    Eur J Pharmacol; 2002 May 17; 443(1-3):43-6. PubMed ID: 12044790
    [Abstract] [Full Text] [Related]

  • 34. Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
    Izzo AA, Mascolo N, Borrelli F, Capasso F.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan 17; 359(1):65-70. PubMed ID: 9933153
    [Abstract] [Full Text] [Related]

  • 35. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
    Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Sep 03; 334(1):R1-2. PubMed ID: 9346339
    [Abstract] [Full Text] [Related]

  • 36. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
    Hoffman AF, Oz M, Caulder T, Lupica CR.
    J Neurosci; 2003 Jun 15; 23(12):4815-20. PubMed ID: 12832502
    [Abstract] [Full Text] [Related]

  • 37. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
    Nilsson O, Fowler CJ, Jacobsson SO.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):165-73. PubMed ID: 16928371
    [Abstract] [Full Text] [Related]

  • 38. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R, Cabezos PA, Vera G, Fernández-Pujol R, Martín MI.
    Neurogastroenterol Motil; 2010 Jun 10; 22(6):694-e206. PubMed ID: 20132133
    [Abstract] [Full Text] [Related]

  • 39. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP, Kraichely DM, Wilken GH, Howlett AC.
    Biochem Pharmacol; 2000 Nov 01; 60(9):1315-23. PubMed ID: 11008125
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ, Brunk LK, Selley DE.
    Eur J Pharmacol; 2001 Mar 02; 414(2-3):135-43. PubMed ID: 11239913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.